rs266879

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000596185.5(KLK3):​n.*112C>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.331 in 232,162 control chromosomes in the GnomAD database, including 13,287 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 8560 hom., cov: 31)
Exomes 𝑓: 0.34 ( 4727 hom. )

Consequence

KLK3
ENST00000596185.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.29

Publications

4 publications found
Variant links:
Genes affected
KLK3 (HGNC:6364): (kallikrein related peptidase 3) Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. The gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. It encodes a single-chain glycoprotein, a protease which is synthesized in the epithelial cells of the prostate gland, and is present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. The serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.374 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLK3NM_001648.2 linkc.46+381C>G intron_variant Intron 1 of 4 ENST00000326003.7 NP_001639.1 P07288-1Q546G3
KLK3NM_001030047.1 linkc.46+381C>G intron_variant Intron 1 of 4 NP_001025218.1 P07288-2
KLK3NM_001030048.1 linkc.46+381C>G intron_variant Intron 1 of 4 NP_001025219.1 P07288-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLK3ENST00000326003.7 linkc.46+381C>G intron_variant Intron 1 of 4 1 NM_001648.2 ENSP00000314151.1 P07288-1

Frequencies

GnomAD3 genomes
AF:
0.327
AC:
49713
AN:
151908
Hom.:
8557
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.293
Gnomad AMI
AF:
0.302
Gnomad AMR
AF:
0.260
Gnomad ASJ
AF:
0.340
Gnomad EAS
AF:
0.0685
Gnomad SAS
AF:
0.260
Gnomad FIN
AF:
0.386
Gnomad MID
AF:
0.362
Gnomad NFE
AF:
0.378
Gnomad OTH
AF:
0.327
GnomAD4 exome
AF:
0.338
AC:
27123
AN:
80132
Hom.:
4727
Cov.:
0
AF XY:
0.334
AC XY:
13965
AN XY:
41768
show subpopulations
African (AFR)
AF:
0.293
AC:
768
AN:
2620
American (AMR)
AF:
0.224
AC:
990
AN:
4422
Ashkenazi Jewish (ASJ)
AF:
0.324
AC:
813
AN:
2510
East Asian (EAS)
AF:
0.0734
AC:
325
AN:
4428
South Asian (SAS)
AF:
0.278
AC:
2260
AN:
8136
European-Finnish (FIN)
AF:
0.385
AC:
1411
AN:
3668
Middle Eastern (MID)
AF:
0.355
AC:
130
AN:
366
European-Non Finnish (NFE)
AF:
0.381
AC:
18791
AN:
49296
Other (OTH)
AF:
0.349
AC:
1635
AN:
4686
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
876
1752
2629
3505
4381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.327
AC:
49740
AN:
152030
Hom.:
8560
Cov.:
31
AF XY:
0.324
AC XY:
24091
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.294
AC:
12167
AN:
41444
American (AMR)
AF:
0.260
AC:
3971
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.340
AC:
1179
AN:
3472
East Asian (EAS)
AF:
0.0690
AC:
357
AN:
5174
South Asian (SAS)
AF:
0.261
AC:
1259
AN:
4824
European-Finnish (FIN)
AF:
0.386
AC:
4078
AN:
10566
Middle Eastern (MID)
AF:
0.354
AC:
104
AN:
294
European-Non Finnish (NFE)
AF:
0.378
AC:
25672
AN:
67962
Other (OTH)
AF:
0.323
AC:
678
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1678
3356
5035
6713
8391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.238
Hom.:
573
Bravo
AF:
0.316
Asia WGS
AF:
0.151
AC:
525
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.034
DANN
Benign
0.55
PhyloP100
-3.3
PromoterAI
-0.0032
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs266879; hg19: chr19-51358638; API